| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/10/2008 | US20080008683 Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins |
| 01/10/2008 | US20080008648 Treatment of Cancer With a Novel Anti-Il13 Monoclonal Antibody |
| 01/10/2008 | DE69133552C5 Deoxyribonucleic acid sequence encoding non-A, non-B hepatitis virus - obtd. Hutch C59 subgroup encoding polypeptide(s), useful as vaccines, and immuno reactive ABS for diagnosis of virus |
| 01/10/2008 | DE19528029B4 Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung Magnetic polymer particles based on polyvinyl alcohol, processes for their preparation and use |
| 01/10/2008 | CA2656771A1 Small streptococcus pyogenes antigens and their use |
| 01/10/2008 | CA2656756A1 Toxin detection method |
| 01/10/2008 | CA2656620A1 Cd20 binding molecules for the treatment of copd |
| 01/10/2008 | CA2656347A1 Composition for modulating the expression of cell adhesion molecules |
| 01/10/2008 | CA2656047A1 Framework selection |
| 01/10/2008 | CA2652058A1 Compositions and methods for modulating immune responses |
| 01/09/2008 | EP1876448A1 Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones. |
| 01/09/2008 | EP1876447A1 Diagnostic agent for tumor |
| 01/09/2008 | EP1876445A1 Antibody directed against gastrin-releasing peptide precursor and use thereof |
| 01/09/2008 | EP1876241A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2008 | EP1876240A1 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1876236A1 Antibody substituting for function of blood coagulation factor viii |
| 01/09/2008 | EP1876233A1 Cells capable of differentiating into cardiac muscle cells |
| 01/09/2008 | EP1876186A1 Prophylactic/therapeutic agent for cancer |
| 01/09/2008 | EP1876185A1 An antibody which recognizes phosphorylated polypeptides |
| 01/09/2008 | EP1875922A2 Intestinal trefoil proteins |
| 01/09/2008 | EP1875237A2 Docetaxel immunoassay |
| 01/09/2008 | EP1874824A2 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 01/09/2008 | EP1874823A2 Cancer specific pcna isoform binding antibodies and uses thereof |
| 01/09/2008 | EP1874822A1 Antibodies and related molecules that bind to psca proteins |
| 01/09/2008 | EP1874821A1 Combination of antibodies and glucocorticoids for treating cancer |
| 01/09/2008 | EP1874820A2 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies |
| 01/09/2008 | EP1874819A2 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 01/09/2008 | EP1874818A2 Tgf beta 1 specific antibodies |
| 01/09/2008 | EP1874817A2 Transgenic animals and methods of making recombinant antibodies |
| 01/09/2008 | EP1874816A2 Modulation of antibody effector function by hinge domain engineering |
| 01/09/2008 | EP1874806A2 Vaccine against burkholderia infections |
| 01/09/2008 | EP1874804A2 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 01/09/2008 | EP1874358A2 Improved stably tethered structures of defined compositions with multiple functions or binding specificities |
| 01/09/2008 | EP1874351A2 Anti-il-6 antibodies, compositions, methods and uses |
| 01/09/2008 | EP1874350A2 Method for treating dementia or alzheimer's disease with a cd20 antibody |
| 01/09/2008 | EP1874349A2 Use of cd25 antibodies in immunotherapy |
| 01/09/2008 | EP1874114A1 Modified animal lacking functional pyy gene, monoclonal antibodies that bind pyy isoforms and uses therefor |
| 01/09/2008 | EP1572917A4 Antibody gene transfer and recombinant aav therefor |
| 01/09/2008 | EP1560848B1 Ptprk immunogenic peptide |
| 01/09/2008 | EP1465922B1 Corticotropin releasing factor receptor 2 agonists |
| 01/09/2008 | EP1411980B1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/09/2008 | EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia |
| 01/09/2008 | EP1040189B1 Polypeptides, their production and use |
| 01/09/2008 | EP0970227B1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/09/2008 | CN101103045A 修饰的Fc分子 Modified Fc molecule |
| 01/09/2008 | CN101103044A Anti-alhpha 9 integrin antibody and the use thereof |
| 01/09/2008 | CN101103043A Kir-binding agents and methods of use thereof |
| 01/09/2008 | CN101103042A IRTA-2 antibodies and their uses |
| 01/09/2008 | CN101102819A Prevention of thrombus formation and/or stabilization |
| 01/09/2008 | CN101102792A Treatment for multiple sclerosis |
| 01/09/2008 | CN101102791A Antibodies against vascular endothelial growth factor receptor-1 |
| 01/09/2008 | CN101100673A Mycobacterium tuberculosis recombination fusion protein and application thereof |
| 01/09/2008 | CN101100663A Preparing method for recombinant human anti-rabies monoclonal antibodies |
| 01/09/2008 | CN101100485A Preparation for angiopoietin-2 haplotype antibody and application technique thereof |
| 01/09/2008 | CN100360937C Assay of isomerised and/or optically inverted proteins and protein fragments |
| 01/09/2008 | CN100360665C I type aldehyde dehydrogenase of clonorchis sinensis, its coding nucleic acid and application |
| 01/09/2008 | CN100360567C RS7 antibodies |
| 01/09/2008 | CN100360566C Pyloric bacillary spirillum resisting yolk immunoglobulin product and its application |
| 01/09/2008 | CN100360565C Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 01/09/2008 | CN100360560C Use of DLP in Pre-mRNA splicing and cell cycle control |
| 01/09/2008 | CN100360183C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/08/2008 | US7317097 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 01/08/2008 | US7317096 Isolated or recombinant nucleic acid sequence encoding an (AAP-1), |
| 01/08/2008 | US7317094 Process for the in vitro culture of different stages of tissular parasites |
| 01/08/2008 | US7317093 PRO1339 antibodies |
| 01/08/2008 | US7317092 Nucleotide sequences coding polypeptide for use in the treatment of skin, kidney, cancer, nervous system, liver and cardiovascular disorders |
| 01/08/2008 | US7317091 Immunogllobulin for use in tissue directed antibody dependent cell-mediated phagocytosis and/or antibody dependent cell-mediated cytotoxicity (ADCC) treatment of cancer, inflammation and cardiovascular disease; immunotherapeutics |
| 01/08/2008 | US7317090 Inhibiting binding of interleukin-4 (IL-4) to an IL-4 Receptor; suppressing an IL-4-dependent immune or inflammatory response in a mammal |
| 01/08/2008 | US7317089 Immunmoglobulin specific to tumor necrosis factor (ligand) superfamily, member 13b (tnfsf13b) protein for use in treatment and prevention of autoimmune, inflammatory, respiratory system, skin , blood and cell proliferative disorders |
| 01/08/2008 | US7317088 PRO5993 polypeptides |
| 01/08/2008 | US7317087 Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof |
| 01/08/2008 | US7317085 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 01/08/2008 | US7317083 PRO4501 polypeptides |
| 01/08/2008 | US7317081 PRO4371 polypeptides |
| 01/08/2008 | US7317078 Screening compounds for receptor agonist and/or antagonist activities. |
| 01/08/2008 | US7317074 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
| 01/08/2008 | US7317003 Small peptides having anti-angiogenic and endothelial cell inhibition activity |
| 01/08/2008 | US7317000 Glucose-dependent insulins |
| 01/08/2008 | US7316912 Tyrosylprotein sulfotransferases and methods of use thereof |
| 01/08/2008 | US7316905 Method for measurement of hepatitis C virus |
| 01/08/2008 | US7316812 Cells expressing anti-Fc receptor binding components |
| 01/08/2008 | CA2225183C Novel foam proteins and use thereof |
| 01/08/2008 | CA2163868C Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 01/08/2008 | CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 01/04/2008 | CA2595164A1 An antibody which recognizes phosphorylated polypeptides |
| 01/03/2008 | WO2008002745A2 Method for a fully automated monoclonal antibody-based extended differential |
| 01/03/2008 | WO2008002285A1 Igy antibodies to human telomerase reverse transcriptase |
| 01/03/2008 | WO2008001063A1 Antibody molecules which bind human il-17 |
| 01/03/2008 | WO2008001045A1 Members of the glycoside hydrolase family 31 family of proteins |
| 01/03/2008 | WO2008000186A1 A method for identifying novel gene and the resulting novel genes |
| 01/03/2008 | WO2008000028A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 01/03/2008 | WO2007124299A3 Antagonist anti-cd40 antibody pharmaceutical compositions |
| 01/03/2008 | WO2007106811A3 Method and composition for treatment of renal disease with antibodies and their equivalents |
| 01/03/2008 | WO2007082105A3 Chlamydia vaccine |
| 01/03/2008 | WO2007064727A3 Penetrabodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases |
| 01/03/2008 | WO2007060550A3 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
| 01/03/2008 | WO2007051077A3 Methods and compounds for lymphoma cell detection and isolation |
| 01/03/2008 | WO2007006581A3 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/03/2008 | WO2005010166A3 P450 oxygenases and methods of use |